Comments
Loading...
Rapport Therapeutics (NASDAQ:RAPP) Stock, Earnings Estimates, EPS, And Revenue
Rapport Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 10
EPS Estimate
$-0.610
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Rapport Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Rapport Therapeutics (RAPP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $-0.50 | $-0.57 | 12.3 % |
| Jun 2024 | 2024-08-08 | $-1.70 | $-0.67 | -153.7 % |
Rapport Therapeutics (RAPP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Rapport Therapeutics (NASDAQ:RAPP) reporting earnings?
Rapport Therapeutics (RAPP) is scheduled to report earnings on February 10, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Rapport Therapeutics (NASDAQ:RAPP)?
The Actual EPS was $-0.50, which beat the estimate of $-0.57.
What were Rapport Therapeutics’s (NASDAQ:RAPP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.